Navigation Links
22,860 SARS-CoV-2 coronavirus tests in 24 hours with NEXTGENPCR
Date:4/1/2020

Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has developed a method using its revolutionary NEXTGENPCR endpoint thermocycler and consumables that decreases PCR amplification time for SARS-CoV-2 to eight minutes. Combined with smaller reaction volumes, increased samples per run, and standard, affordable laboratory equipment, a qualitative protocol was generated that could readily detect SARS-CoV-2 control DNA, with equivalent sensitivity. A single unit, the size of a shoebox, could perform a hundred and eighty (180) amplification runs a day, an almost ten-fold increase over the current US Centers for Disease Control (CDC) recommended instrumentation. Detection of amplified product can be done with widely-available blue light gel document systems.

“We sought to decrease what we identified as the longest step in the current testing scheme, amplification,” says MBS CEO and founder, Gert de Vos. “We started with the CDC assay because it is well characterized and has been readily available.”

Since the NEXTGENPCR accepts both 96 and 384-well reaction plates, MBS tested both versions to increase throughput. By utilizing 384-well plates, the machine successfully processed four times as many samples without a loss in performance. The 384-well reaction chambers only require twenty-five percent of the reaction volume which would lower the supply burden placed on laboratories following the current CDC protocol.

NEXTGENPCR machines launched about two years ago and are available globally. Gert de Vos stated, "This protocol produces a simple yes/no answer — so a single machine, is capable of running 24/7, with 8-minute runs may provide a scalable screening solution analyzing 22,860 samples per day.”

MBS is now collaborating with testing laboratories in the USA and the Netherlands to transfer and validate the method.

Find out more at http://www.nextgenpcr.com

About Molecular Biology Systems
Molecular Biology Systems, B.V., founded in 2015, is a molecular biology solutions company based in Netherlands. Their NEXTGENPCR thermocycler uses patented heating and cooling technology to reduce PCR amplification cycles from hours to minutes. These technological advances are intended to support laboratorians across the life sciences market reduce costs and accelerate results.

All referenced product names, and other marks, are trademarks of their respective owners.
© 2020 Molecular Biology Systems, B.V. All rights reserved.

Read the full story at https://www.prweb.com/releases/22_860_sars_cov_2_coronavirus_tests_in_24_hours_with_nextgenpcr/prweb17016355.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Carterra® Inc. Selected by the La Jolla Institute of Immunology to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)
2. University Of Colorado Cancer Center Tests Promising New Drug to Treat and Protect Against Radiotherapy-Associated Oral Mucositis
3. Neogen launches rapid tests for ractopamine
4. TessArae, LLC and Chinese esoteric laboratory, Kindstar Global, secure partnership for development of genetic tests.
5. New Tests May Help Determine Whether or Not You are More Prone to Acne Causing Bacteria, Probiotic Action Explains
6. RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response
7. Express Diagnostics Introducing New Products and Expanded Catalog of Drug Tests at the 2013 AACC Clinical Lab Expo
8. Follow-up Tests Confirm Success of Enviro-Equipment Inc.’s Powdered Activated Carbon (PAC) CleanInject® Remediation System
9. Ventana to collaborate with Boehringer Ingelheim on the development of companion diagnostic tests
10. DiaCarta Inc. Launches QClamp™ Somatic Mutation Real-Time PCR Tests for KRAS, NRAS, EGFR, BRAF, PIK3CA and More Without DNA Extractions
11. Exclusive News From ARD German TV News Programme: New Methods for Detecting Anabolic Steroids Lead to Hundreds of Positive Doping Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/10/2020)... ... July 09, 2020 , ... In ... commonly used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to ... by Dr MA has been using the zebrafish model to investigate the causes ...
(Date:7/7/2020)... (PRWEB) , ... July 06, 2020 , ... R3 International ... program featuring up to 200 million stem cells. Depending on the patient's condition, treatment ... in the US will die having some form of Alzheimers dementia, and the incidence ...
(Date:7/1/2020)... CHARLOTTE, N.C. (PRWEB) , ... June 29, 2020 ... ... has reported year to date growth of 40% in 2020, despite many obstacles ... medical technology, MedShift aims to increase revenue for its partnered medical practices and ...
Breaking Biology Technology:
(Date:8/21/2020)... LEXINGTON, Mass. (PRWEB) , ... August 18, 2020 ... ... novel approaches to cell therapy, today announced that the U.S. Food and Drug ... evaluation of Sentien’s lead asset, SBI-101, for the treatment of severe COVID-19. Approval ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio ... are ideal for public health agencies of all sizes. With a focus on ... at-risk individuals find appropriate health care, Mosio helps public health departments automate communications ...
(Date:7/31/2020)... (PRWEB) , ... July 30, 2020 , ... ... Research (SBIR) Phase II contract awarded by the Joint Science & Technology Office—Chemical ... this project is to develop, optimize, and scale-up a highly efficient mammalian cell ...
Breaking Biology News(10 mins):